Sport-Related Portal Vein Thrombosis: An Unusual Complication

Dumić, Igor; Tankosic, Nikola; Lalosevic, Milica Stojkovic; Alempijević, Tamara

doi:10.1155/2017/9324246

Cited by 4 publications

(4 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Noncirrhotic, nonmalignant PVT is rare and is usually associated with infection, trauma, or prothrombic disorder. In about 25 percent of cases, the etiology remains elusive despite extensive workup [3]. Pylephlebitis (suppurative thrombophlebitis of the portal vein) is a rare complication of intra-abdominal or pelvic infection [4].…”

Section: Discussionmentioning

confidence: 99%

“…Lemierre's syndrome is a classic example of human necrobacillosis wherein acute primary infection of oropharynx is followed by secondary septic thrombophlebitis of internal jugular vein and subsequent septic embolization at various sites [2]. Pylephlebitis (suppurative, infected portal vein thrombosis (PVT)) is a rare but serious complication of intra-abdominal or pelvic infection and is associated with significant morbidity and mortality [3,4]. Pylephlebitis due to F. necrophorum, also known as abdominal variant of Lemierre's syndrome, has been rarely reported.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Fusobacterium necrophorum subsp. necrophorum Liver Abscess with Pylephlebitis: An Abdominal Variant of Lemierre’s Syndrome

Radovanović

Dumić

Veselinovic

et al. 2020

Case Reports in Infectious Diseases

Self Cite

View full text Add to dashboard Cite

Liver abscess associated with suppurative portal vein thrombosis (pylephlebitis) secondary to Fusobacterium necrophorum has been rarely reported. It is considered to be an abdominal variant of Lemierre’s syndrome associated with significant morbidity and mortality. We report a case of 69-year-old man who developed liver abscess and pylephlebitis due to F. necrophorum with an unclear source of infection. We discuss the pathogenesis, diagnosis, and treatment strategy for this entity, with a review of previously published cases of pyelephlebitis due to F. necrophorum in regard to their clinical presentation and outcome.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Fusobacterium necrophorum subsp. necrophorum Liver Abscess with Pylephlebitis: An Abdominal Variant of Lemierre’s Syndrome

Radovanović

Dumić

Veselinovic

et al. 2020

Case Reports in Infectious Diseases

Self Cite

View full text Add to dashboard Cite

show abstract

“…Eventually, PVT has been related to sports injuries. Dumic et al reported a case of PVT secondary to abdominal trauma related to the practice of brazilian jiu-jitsu in a 32-year-old man with no other traditional risk factors for PVT [ 71 ]; other cases have been described as correlated with decompression sickness in a 48-year-old deep sea self-contained underwater breathing apparatus (SCUBA) diver [ 72 ] and with kickboxing [ 73 ].…”

Section: Risk Factors For Portal Vein Thrombosismentioning

confidence: 99%

Portal Vein Thrombosis: State-of-the-Art Review

Boccatonda,

Gentilini,

Zanata

et al. 2024

JCM

View full text Add to dashboard Cite

Background: Portal vein thrombosis (PVT) is a rare disease with an estimated incidence of 2 to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are chronic liver diseases (cirrhosis), primary or secondary hepatobiliary malignancy, major infectious or inflammatory abdominal disease, or myeloproliferative disorders. Methods: PVT can be classified on the basis of the anatomical site, the degree of venous occlusion, and the timing and type of presentation. The main differential diagnosis of PVT, both acute and chronic, is malignant portal vein invasion, most frequently by hepatocarcinoma, or constriction (typically by pancreatic cancer or cholangiocarcinoma). Results: The management of PVT is based on anticoagulation and the treatment of predisposing conditions. The aim of anticoagulation in acute thrombosis is to prevent the extension of the clot and enable the recanalization of the vein to avoid the development of complications, such as intestinal infarction and portal hypertension. Conclusions: The treatment with anticoagulant therapy favors the reduction of portal hypertension, and this allows for a decrease in the risk of bleeding, especially in patients with esophageal varices. The anticoagulant treatment is generally recommended for at least three to six months. Prosecution of anticoagulation is advised until recanalization or lifelong if the patient has an underlying permanent pro-coagulant condition that cannot be corrected or if there is thrombosis extending to the mesenteric veins.

show abstract

“…(5) Trauma: Severe abdominal or liver trauma can damage the portal vein and initiate clotting. There have even been reports of portal vein thrombosis related to abdominal trauma [6] and injuries associated with sports activities [7].…”

Section: Introductionmentioning

confidence: 99%

Portal Vein Thrombosis in Liver Transplantation: A Retrospective Cohort Study

Barrera-Lozano

Ramírez-Arbeláez

Muñoz

et al. 2023

JCM

View full text Add to dashboard Cite

Portal vein thrombosis was considered a contraindication for liver transplantation. This study analyzes the perioperative complications and survival of liver transplant patients with portal vein thrombosis (PVT). A retrospective observational cohort study of liver transplant patients was conducted. The outcomes were early mortality (30 days) and patient survival. A total of 201 liver transplant patients were identified and 34 (17%) patients with PVT were found. The most frequent extension of thrombosis was Yerdel 1 (58.8%), and a portosystemic shunt was identified in 23 (68%) patients. Eleven patients (33%) presented any early vascular complication, PVT being the most frequent (12%). The multivariate regression analysis showed a statistically significant association between PVT and early complications (OR = 3.3, 95% confidence interval 1.4–7.7; p = 0.006). Moreover, early mortality was observed in eight patients (24%), of which two (5.9%) presented Yerdel 2. For Yerdel 1, patient survival according to the extent of thrombosis was 75% at 1 year and 3 years, while for Yerdel 2, it was 65% at 1 year, and 50% at 3 years (p = 0.04). Portal vein thrombosis significantly influenced early vascular complications. Furthermore, portal vein thrombosis Yerdel 2 or higher impacts the survival of liver grafts in the short and long term.

show abstract

Sport-Related Portal Vein Thrombosis: An Unusual Complication

Cited by 4 publications

References 21 publications

Fusobacterium necrophorum subsp. necrophorum Liver Abscess with Pylephlebitis: An Abdominal Variant of Lemierre’s Syndrome

Fusobacterium necrophorum subsp. necrophorum Liver Abscess with Pylephlebitis: An Abdominal Variant of Lemierre’s Syndrome

Portal Vein Thrombosis: State-of-the-Art Review

Portal Vein Thrombosis in Liver Transplantation: A Retrospective Cohort Study

Contact Info

Product

Resources

About